| 发明名称 |
Azaindole derivative |
| 摘要 |
The purpose of the present invention is to provide a novel compound having a selective JAK3-inhibiting effect and excellent oral absorption. Moreover, the purpose of the present invention is to provide a medical drug useful, on the basis of a JAK3-inhibiting effect, for the prevention and/or treatment of JAK3-associated disease, particularly rheumatoid arthritis or multiple sclerosis. Provided is an azaindole derivative, or a salt thereof, having a cycloalkenyl group that is represented by formula (I) [where R |
| 申请公布号 |
AU2015215582(A1) |
申请公布日期 |
2016.07.14 |
| 申请号 |
AU20150215582 |
申请日期 |
2015.02.04 |
| 申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
NAKAMURA, MASAYUKI;YAMANAKA, HIROYOSHI;SHIBATA, KAZUAKI;MITSUYA, MORIHIRO;HARADA, TAKAFUMI |
| 分类号 |
C07D471/04;A61K31/437;A61K31/444;A61P1/04;A61P3/10;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/28;A61P27/14;A61P27/16;A61P29/00;A61P31/12;A61P35/00;A61P35/02;A61P37/02;A61P37/06;A61P37/08;A61P43/00 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
